Kelli A. Reardon
University of Virginia
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Kelli A. Reardon.
International Journal of Radiation Oncology Biology Physics | 2008
Wensha Yang; Paul W. Read; Jun Mi; Joseph M. Baisden; Kelli A. Reardon; James M. Larner; Brian P. Helmke; Ke Sheng
PURPOSE It has been proposed that quantum dots (QDs) can be used to excite conjugated photosensitizers and produce cytotoxic singlet oxygen. To study the potential of using such a conjugate synergistically with radiotherapy to enhance cell killing, we investigated the energy transfer from megavoltage (MV) X-rays to a photosensitizer using QDs as the mediator and quantitated the enhancement in cell killing. METHODS AND MATERIALS The photon emission efficiency of QDs on excitation by 6-MV X-rays was measured using dose rates of 100-600 cGy/min. A QD-Photofrin conjugate was synthesized by formation of an amide bond. The role of Förster resonance energy transfer in the energy transferred to the Photofrin was determined by measuring the degree of quenching at different QD/Photofrin molar ratios. The enhancement of H460 human lung carcinoma cell killing by radiation in the presence of the conjugates was studied using a clonogenic survival assay. RESULTS The number of visible photons generated from QDs excited by 6-MV X-rays was linearly proportional to the radiation dose rate. The Förster resonance energy transfer efficiency approached 100% as the number of Photofrin molecules conjugated to the QDs increased. The combination of the conjugate with radiation resulted in significantly lower H460 cell survival in clonogenic assays compared with radiation alone. CONCLUSION The novel QD-Photofrin conjugate shows promise as a mediator for enhanced cell killing through a linear and highly efficient energy transfer from X-rays to Photofrin.
Medical Dosimetry | 2013
Kelli A. Reardon; Paul W. Read; Monica M. Morris; Michael A. Reardon; C. Geesey; K. Wijesooriya
Patients undergoing radiation for left-sided breast cancer have increased rates of coronary artery disease. Free-breathing intensity-modulated radiation therapy (FB-IMRT) and 3-dimensional conformal deep inspiratory-breath hold (3D-DIBH) reduce cardiac irradiation. The purpose of this study is to compare the dose to organs at risk in FB-IMRT vs 3D-DIBH for patients with left-sided breast cancer. Ten patients with left-sided breast cancer had 2 computed tomography scans: free breathing and voluntary DIBH. Optimization of the IMRT plan was performed on the free-breathing scan using 6 noncoplanar tangential beams. The 3D-DIBH plan was optimized on the DIBH scan and used standard tangents. Mean volumes of the heart, the left anterior descending coronary artery (LAD), the total lung, and the right breast receiving 5% to 95% (5% increments) of the prescription dose were calculated. Mean volumes of the heart and the LAD were lower (p<0.05) in 3D-DIBH for volumes receiving 5% to 80% of the prescription dose for the heart and 5% for the LAD. Mean dose to the LAD and heart were lower in 3D-DIBH (p≤0.01). Mean volumes of the total lung were lower in FB-IMRT for dose levels 20% to 75% (p<0.05), but mean dose was not different. Mean volumes of the right breast were not different for any dose; however, mean dose was lower for 3D-DIBH (p = 0.04). 3D-DIBH is an alternative approach to FB-IMRT that provides a clinically equivalent treatment for patients with left-sided breast cancer while sparing organs at risk with increased ease of implementation.
Rare Tumors | 2010
Kelli A. Reardon; Michael A. Reardon; Christopher A. Moskaluk; William W. Grosh; Paul W. Read
We report a case of a primary pericardial malignant mesothelioma. A 59-year-old male presented with episodic chest pain and dyspnea on exertion. Cardiac magnetic resonance imaging revealed a large mass in the pericardium attached to the right ventricle. Partial resection of the mass was undertaken revealing malignant mesothelioma, byphasic type. The patient was treated with chemotherapy intermittently over a period of 3 years, but his disease continued to progress. The patient was then treated with definitive radiation therapy to 64 Gy to the primary tumor using a six field 3D conformal technique. The patient remains free of progressive disease 86 months from the time of diagnosis and 50 months from the completion of his radiotherapy.
Future Oncology | 2015
Daniel M. Trifiletti; Ryan Jones; Shayna L. Showalter; Bruce Libby; David R. Brenin; Anneke T. Schroen; Monica M. Morris; Kelli A. Reardon; Timothy N. Showalter
Intraoperative radiation therapy (IORT) is a method of accelerated partial breast irradiation developed to replace other longer courses of radiotherapy with a single radiation session administered at the time of breast-conserving surgery. The purpose of this review is to summarize the advantages and disadvantages of breast IORT techniques that are currently available, as well to consider potential alternative techniques for breast IORT or ultra-short course breast radiotherapy. Furthermore, we highlight the published outcomes for the IORT treatment approaches including: electron therapy, superficial photon therapy and other techniques. Potential future directions of IORT are explored including novel IORT techniques utilizing intraoperative brachytherapy with in-room imaging and rapid treatment planning.
Breast Cancer: Targets and Therapy | 2015
Daniel M. Trifiletti; Kara D. Romano; Shayna L. Showalter; Kelli A. Reardon; Bruce Libby; Timothy N. Showalter
Accelerated partial breast irradiation (APBI) through breast brachytherapy is a relatively recent development in breast radiotherapy that has gained international favor because of its reduction in treatment duration and normal tissue irradiation while maintaining favorable cancer-specific and cosmetic outcomes. Despite the fact that several large national trials have not reported final results yet, many providers are currently offering APBI to select patients and APBI is listed as a treatment option for selecting patients in the National Comprehensive Cancer Network guidelines. Multiple consensus guidelines exist in selecting patients for APBI, some with conflicting recommendations. In this review, the existing patient selection guidelines are reported, compared, and critiqued, grouping them in helpful subcategories. Unique patient and technical selection factors for APBI with brachytherapy are explored.
Brachytherapy | 2015
Daniel M. Trifiletti; Timothy N. Showalter; Bruce Libby; David R. Brenin; Anneke T. Schroen; Kelli A. Reardon; Shayna L. Showalter
PURPOSE Intraoperative radiation therapy (IORT) is an increasingly popular approach to breast conserving therapy in the treatment of early-stage breast cancer. A drawback to IORT compared with postoperative adjuvant radiation therapy is that it is not performed using image guidance. Our aim was to report on how our institutions unique IORT workflow integrates CT image guidance and how these CT images were used intraoperatively to change applicator positioning. METHODS AND MATERIALS We retrospectively reviewed the first 29 patients who participated in a prospective clinical trial of breast IORT at our institution. All patients underwent lumpectomy, multicatheter balloon placement, intraoperative CT scan, and high-dose-rate brachytherapy treatment delivery to 12.5 Gy to 1 cm from the balloon surface. This report focuses on the intraoperative CT findings that led to clinical changes, followed by repeat CT for IORT treatment planning. RESULTS After initial intraoperative CT, 7 patients underwent an additional intraoperative CT scan (24.1%). In 6 patients, the initial intraoperative CT scan identified large air cavities and/or poor tissue conformity. This defect could be improved in all patients with adjustment of the balloon applicator before planning and delivering IORT. Intraoperative CT scan was used in one patient to localize a biopsy clip and aided in excision to negative margin. CONCLUSIONS In our study, intraoperative CT identifies actionable findings in breast IORT, including residual tumor or errors in applicator positioning, in almost 25% of patients. Clinical results of the described trial will serve to further validate this image-guided approach to IORT.
Journal of Radiotherapy in Practice | 2016
Daniel M. Trifiletti; K. Wijesooriya; G. Moyer; D. Lain; C. Geesey; K. Forbes; Kelli A. Reardon
Aim Deep inspiratory breath hold (DIBH) during left-breast irradiation helps to minimise cardiac irradiation by physically separating the heart from the left breast. The dose to organs-at-risk in intensity-modulated radiotherapy (IMRT) and opposed tangent three-dimensional conformal radiotherapy (3DCRT) during DIBH in patients with left-sided breast cancer was compared. Materials and methods A total of 20 consecutive patients with left-sided breast cancer had a computed tomography scan utilising DIBH. Mean volumes of the heart, left anterior descending coronary artery, total lung and right breast receiving 5–95% of the prescription dose were calculated. Results Target volume homogeneity was improved with IMRT and average mean dose to target was higher for 3DCRT (51·03 Gy) compared with IMRT (50·47 Gy, p p p p Findings Under DIBH, absolute differences between 3DCRT and IMRT were minimal. 3DCRT under DIBH provided excellent dosimetric results in most patients with left-sided breast cancer without the need for IMRT.
Medical Physics | 2013
Bruce Libby; L. Handsfield; Kelli A. Reardon; Timothy N. Showalter
PURPOSE Use of heterogeneity correction has only recently been applied in brachytherapy. Vaginal packing with gauze is used in gynecological brachytherapy to physically move the bladder and rectum farther from the applicator, reducing dose to these structures. The Alatus balloon packing system accomplishes the same task, but use of contrast in the balloon can also obscure these structures on CT images. This work was designed, and conducted using a prostate phantom, to determine the optimal contrast concentration in terms of streak artifact and noise and whether patient anatomy would be obscured by high contrast concentration. METHODS A 60 cc syringe was filled with Omnipaque contrast liquid (350 mg I/ml) of varying concentrations (100% contrast to pure water as well as air) and placed in the phantom rectum in a CIRS prostate phantom (used to permit consistent measurement CT scan was then acquired. The mean CT number of a region of interest inside the prostate was determined, along with the percent noise. Additionally, the distance between the rectum and prostate was determined to see if resolution near the high density material was lost. RESULTS The mean CT number of the region of interest did not change from air or water in the syringe through the 100% contrast scan, but the noise increased from 12% to 33%. In all scans the 2 mm distance from the edge of the rectum to the prostate was readily seen. CONCLUSION Previous work has shown that overriding the density in the Alatus balloon packing system for gynecological brachytherapy can lead to additionally radioprotection of the bladder and rectum. This study shows that use of undiluted contrast does not lead to unacceptable streak artifacts that would obscure anatomy, and can be clinically implemented.
International Journal of Radiation Oncology Biology Physics | 2016
Shayna L. Showalter; Gina R. Petroni; Daniel M. Trifiletti; Bruce Libby; Anneke T. Schroen; David R. Brenin; Parchayi Dalal; Mark E. Smolkin; Kelli A. Reardon; Timothy N. Showalter
Brachytherapy | 2014
Ryan Jones; Bruce Libby; Shayna L. Showalter; David R. Brenin; David D. Wilson; Anneke T. Schroen; Monica M. Morris; Kelli A. Reardon; John Morrison; Timothy N. Showalter